Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach

from Blood Cancer Talks · host Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff

In this episode, we discuss the comeback of belantamab mafadotin in multiple myeloma with Dr. Hang Quach, along with some other important abstracts presented at EHA/ASCO 2024. Here are the studies we discussed: 1. DREAMM-7 RCT: Belantamab-Vd vs Daratumumab-Vd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828933/2. DREAMM-8 RCT: Belantamab-Pd vs PVd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828951/3. Long-term follow-up of CASSIOPEIA Trial: https://pubmed.ncbi.nlm.nih.gov/38889735/4. Update on MRD data from PERSEUS Trial: https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.7502

Episode metadata supplied by the publisher feed · Published Nov 13, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach

0:00 44:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Blood Cancer Talks?

This episode is 44 minutes long.

When was this Blood Cancer Talks episode published?

This episode was published on November 13, 2024.

Can I download this Blood Cancer Talks episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!